Clinical Trial Update: SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the combination of SU5416 and paclitaxel in patients with recurrent, locally advanced, or metastatic head and neck cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• SU5416 (semaxanib)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED